Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningbo G-H Pharma is a specialized Contract Development and Manufacturing Organization (CDMO) focused on small molecule active pharmaceutical ingredients (APIs) and advanced intermediates. Headquartered in Ningbo, China, the company offers integrated services ranging from process chemistry and analytical development to pilot-scale and commercial-scale GMP manufacturing. The leadership team consists of industry experts with significant experience in global pharmaceutical R&D and manufacturing standards. Ningbo G-H Pharma operates state-of-the-art facilities designed to meet international regulatory requirements, serving biotech and pharmaceutical clients worldwide. Their core competencies include complex chemical synthesis, process optimization, and ensuring high-quality standards for clinical and commercial supply. The company is positioned as a high-end service provider for the global life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ningbo G-H Pharma.